AVTX
Price
$4.90
Change
-$0.05 (-1.01%)
Updated
Jul 10 closing price
Capitalization
53.6M
MRSN
Price
$0.38
Change
+$0.04 (+11.76%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
42.03M
27 days until earnings call
Interact to see
Advertisement

AVTX vs MRSN

Header iconAVTX vs MRSN Comparison
Open Charts AVTX vs MRSNBanner chart's image
Avalo Therapeutics
Price$4.90
Change-$0.05 (-1.01%)
Volume$21.17K
Capitalization53.6M
Mersana Therapeutics
Price$0.38
Change+$0.04 (+11.76%)
Volume$30.46K
Capitalization42.03M
AVTX vs MRSN Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. MRSN commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Buy and MRSN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (AVTX: $4.90 vs. MRSN: $0.38)
Brand notoriety: AVTX and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 24% vs. MRSN: 212%
Market capitalization -- AVTX: $53.6M vs. MRSN: $42.03M
AVTX [@Biotechnology] is valued at $53.6M. MRSN’s [@Biotechnology] market capitalization is $42.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while MRSN’s TA Score has 6 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 2 bearish.
  • MRSN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than MRSN.

Price Growth

AVTX (@Biotechnology) experienced а -1.21% price change this week, while MRSN (@Biotechnology) price change was +31.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

AVTX is expected to report earnings on May 12, 2025.

MRSN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($53.6M) has a higher market cap than MRSN($42M). AVTX YTD gains are higher at: -34.051 vs. MRSN (-73.427). AVTX has higher annual earnings (EBITDA): -50.14M vs. MRSN (-68.42M). AVTX has more cash in the bank: 125M vs. MRSN (102M). AVTX has less debt than MRSN: AVTX (801K) vs MRSN (24.6M). MRSN has higher revenues than AVTX: MRSN (34M) vs AVTX (441K).
AVTXMRSNAVTX / MRSN
Capitalization53.6M42M128%
EBITDA-50.14M-68.42M73%
Gain YTD-34.051-73.42746%
P/E Ratio0.04N/A-
Revenue441K34M1%
Total Cash125M102M123%
Total Debt801K24.6M3%
FUNDAMENTALS RATINGS
AVTX vs MRSN: Fundamental Ratings
AVTX
MRSN
OUTLOOK RATING
1..100
2415
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5100
PRICE GROWTH RATING
1..100
6465
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (84) in the Pharmaceuticals Other industry is in the same range as MRSN (88) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's SMR Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than MRSN’s over the last 12 months.

AVTX's Price Growth Rating (64) in the Pharmaceuticals Other industry is in the same range as MRSN (65) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's P/E Growth Rating (98) in the Pharmaceuticals Other industry is in the same range as MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXMRSN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRRPF0.43N/A
N/A
Torrent Cap Ltd
JUTOY23.67N/A
N/A
Jutal Offshore Oil Service Ltd.
UEPCN76.25N/A
N/A
Union Electric Co.
UNIRF4.28N/A
N/A
Unibail Rodamco
HROGF6.82N/A
N/A
Hirogin Holdings Inc.

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-1.01%
FGEN - AVTX
57%
Loosely correlated
+18.74%
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
+12.69%
PGEN - AVTX
34%
Loosely correlated
+0.53%
BDRX - AVTX
32%
Poorly correlated
+1.40%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+12.69%
IGMS - MRSN
54%
Loosely correlated
+0.74%
CRNX - MRSN
48%
Loosely correlated
-1.05%
DYN - MRSN
47%
Loosely correlated
-0.90%
DNLI - MRSN
42%
Loosely correlated
+2.33%
RGNX - MRSN
42%
Loosely correlated
-1.20%
More